legislation: 106-s-2993

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id	congress	bill_type	bill_number	title	policy_area	introduced_date	latest_action_date	latest_action_text	origin_chamber	sponsor_name	sponsor_state	sponsor_party	sponsor_bioguide_id	cosponsor_count	summary_text	update_date	url
106-s-2993	106	s	2993	Drug Competition Act of 2000	Commerce	2000-07-27	2000-07-27	Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S7908-7909)	Senate	Sen. Leahy, Patrick J. [D-VT]	VT	D	L000174	1	Drug Competition Act of 2000 - Requires brand name drug manufacturers and generic drug manufacturers to file with the Federal Trade Commission and the Attorney General agreements affecting the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product.	2025-08-20T14:16:50Z

Links from other tables

3 rows from bill_id in legislation_actions
19 rows from bill_id in legislation_subjects
1 row from bill_id in legislation_cosponsors
0 rows from bill_id in cbo_cost_estimates